由CD28-ARS2轴驱动的PKM替代拼接引起的CD8+T细胞代谢灵活性支持抗瘤免疫力
相关实验视频
Updated: Jul 5, 2025

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
278
G Aaron Holling1,2, Colin A Chavel1, Anand P Sharda1
1Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Cellular & molecular immunology
|January 17, 2024
概括
一个新的CD28-ARS2信号轴重编程CD8+T细胞代谢,增强它们对抗瘤的能力. 这一途径影响葡萄糖利用和细胞因子的产生,这对于有效的抗瘤免疫是至关重要的.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞的新陈代谢
- 分子生物学分子生物学
背景情况:
- 代谢灵活性对于CD8+T细胞抗瘤活性至关重要.
- 调节T细胞代谢灵活性的机制在很大程度上是未知的.
研究的目的:
- 研究ARS2在成熟T细胞中的作用.
- 阐明控制CD8+T细胞代谢灵活性的信号通路.
主要方法:
- 研究了ARS2对成熟T细胞的影响.
- 分析了CD28信号传递及其对基因拼接和新陈代谢的下游影响.
- 检查的酸盐激酶 (PKM) 替代拼接.
主要成果:
- 在激活的CD8+T细胞中发现了一种新的CD28-ARS2信号轴.
- ARS2上调影响大约三分之一的T细胞激活诱导事件的替代拼接.
- CD28-ARS2轴促进PKM2表达超过PKM1,影响葡萄糖代谢和效应器功能.
- PKM的替代拼接独立于PI3K通路激活发生.
结论:
- CD28-ARS2轴是CD8+T细胞葡萄糖代谢的新型调节者.
- 这一途径增强了T细胞的代谢灵活性和抗瘤作用因子功能.
- 辅助刺激通过独立于PI3K信号传递的新机制重新编程T细胞代谢.
相关概念视频
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527

